F
$ Value
$50K
Shares
14,280
Price
$3
Filed
Feb 19
Insider
Name
Khan Najat
Title
CEO and President
CIK
0002020969
Roles
Director
Officer
Transaction Details
Transaction Date
2026-02-17
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,290,383
Footnotes
Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
Filing Info
Khan Najat's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-17 | RXRX | F | $50K |
| 2026-02-06 | RXRX | A | $0 |
| 2026-02-06 | RXRX | A | $0 |
| 2026-02-06 | RXRX | F | $41K |
| 2025-12-22 | RXRX | ▼ | $549K |
| 2025-11-17 | RXRX | F | $73K |
| 2025-11-05 | RXRX | A | $0 |
| 2025-11-05 | RXRX | A | $0 |
| 2025-08-18 | RXRX | ▼ | $202K |
| 2025-08-15 | RXRX | F | $21K |
Other Insiders at RXRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Taylor Ben R
Chief Financial Officer
|
— | $41K | 2026-04-06 |
| Li Dean Y | — | — | 2026-04-01 |
| Dar Zavain | — | — | 2026-04-01 |
| Borgeson Blake | — | $1.0M | 2026-04-07 |
| Gibson Christopher | — | $557K | 2026-04-07 |
|
Hallett David
Chief Scientific Officer
|
— | — | 2026-02-17 |
|
Khan Najat
CEO and President
|
— | — | 2026-02-06 |